Sunday, August 08, 2021 12:42:28 AM
* BLA submission by end of 1st qtr, 2019.
* amfAR trial starting. (ghost trial)
* BLA RTF was about "syringe Mfgr".
* "I didn't say applied for an EUA".(i have a Mulholland e-mail claiming the same)
* 1k times better than Remdesivir.
* Insinuated pharma offered Cytodyn less than market normal 15% for a company.(no SEC proof)
* May 2020 CC, "i took no salary 1st year '08.(was paid $200k via a PSA contract: character).
* I sold $15m to help Mfgr. (still no SEC proof: character)
* I could sell to other countries right now.
* Guarantee BLA approval --"would you agree Dr. Rahman?" (he didn't)
* Have been in contact with OWS. (WSJ reported it was an OWS refused application)
* We filed for a conditional EUA. (technically, there was a "covid conditional" policy)
* We will file IO by June. (@ June, said not enough staff to complete filing, but no job listings)
* We will file PH EUA this week. (over 2 months ago)
* Me & SK are going to NY to complete talks.(4 months ago)
* We did not apply for USG grants because it might complicate partnership talks in the future.(???!!)
* We have a Ph PO.
* We will release the PO amount when feel it's significant.
* We will release RTF ROC letter to website.(over 1 month ago)
* SEC "Statement".(he agreed LL did not prove news statements)
* Fully funded through the year & non-dilutive.
* "394" data as positive due "confidential" with 3 countries.
* Did not release DOJ subpoenas & called it "confidential".
* Pestell case says he lied to the BOD about Pestell intentions.
* Derivative judge said he withheld info & lied to enrich himself.
Wonder why the DOJ would now be in the building.
For every single form of communication.
Most likely looking @ the way things were presented to the market: vague, not true, misleading, incorrect,
"knowingly" fraudulent --- etc, etc, & compared to share price & the questionable funding source.
Who by the funding agreement, "may loan shares for shorting", etc..
Finding out if Cytodyn hired securities & criminal defense attorney(s), will speak a lot to the SEC / DOJ issues.
Nader Pourhassan is very possibly in deep trouble.
This drug should be baggage free & saving thousands per day.
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM